Enter a job title or keyword

Senior Global Market Access Lead


Job Location:

Bengaluru - India

Monthly Salary: Not provided by the employer
Posted: 6 July 2026 (30+ days ago)
Application Deadline: 3 October 2026
Vacancies: 1 Vacancy

Job Summary

Your new role

As Senior Global Market Access Lead you will own and drive market access and payer value strategy across

pipeline launch and lifecycle stages for assigned diabetes assets. Operating with high independence you will

integrate payer insight HTA strategy and value communication into the heart of asset development –

influencing how our therapies reach patients in 194 countries.

Day-to-day your responsibilities will include:

Owning asset-level market access and payer value strategy integrating payer research Target Access

Profile (TAP) and access risk assessment across pipeline launch and lifecycle stages

Leading the development and refinement of TAPs market access business cases and global payer

value communication toolsets (eCVDs value decks negotiation toolkits) in collaboration with Pricing

and HEOR

Shaping HTA and reimbursement strategy packages including submission sequencing plans risk

assessments and high-complexity affiliate support for HTA submissions payer negotiations and

objection handling

Providing market access input into clinical development planning including early access strategy HTA

risk assessment and evidence needs

Driving payer insight generation to inform access strategy value messaging and evidence

requirements

Acting as informal market access matrix lead for assigned assets – coordinating cross-functional

stakeholders across Clinical Medical Commercial Regulatory and affiliate teams

Leading internal and affiliate-facing training on asset-specific access strategy and payer value

communication and mentoring junior and mid-level colleagues across the team

Your new department

In Product & Portfolio Strategy we drive commercial strategy medical affairs and business development across

all therapy areas. We act as a connector and compass guiding the new Novo Nordisk portfolio for sustained

competitiveness upstream and maximising portfolio potential through successful commercial strategies and

competitive launches downstream.

You will join Global Market Access and Pricing – Diabetes & Access the team responsible for defining shaping

and operationalising payer-relevant value and access strategies across the asset lifecycle. We work at the

intersection of science evidence and health systems – partnering closely with HEOR Pricing Payer Evidence

Clinical Development Medical Commercial and regional/affiliate teams to ensure payer insights and access

strategy are embedded into pipeline development launch preparation and lifecycle management.

Your skills & qualifications

We are looking for a strategic payer-savvy market access professional who thrives in high-ambiguity

environments and enjoys turning complex evidence into clear access outcomes. You'll bring with you:

A Master's degree or higher in Health Economics Public Health Pharmacy Epidemiology Biostatistics

Health Services Research or a closely related quantitative/health discipline with formal training or

demonstrated experience in Market Access Value Strategy Payer Engagement or Health Economics

6–10 years of relevant experience with clear ownership of asset-level market access strategy including

payer research TAP development HTA planning and launch preparation

Strong understanding of payer systems HTA processes and reimbursement pathways across key

markets combined with knowledge of payer research methods and the ability to translate insight into

coherent access strategy

Demonstrated ability to develop and refine TAPs market access business cases and payer value

narratives – integrating pricing HEOR and payer evidence inputs into a single defensible story

Proven success operating in a global matrix environment with advanced stakeholder management

strong project leadership and excellent written and verbal communication skills in English

Sound judgement in balancing access ambition with evidence readiness and launch constraints and

the personal resilience to navigate shifting payer feedback and strategic priorities

The role is global in scope with up to 5% international travel and virtual collaboration across time zones.